Literature DB >> 2569190

High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor.

J E Wikberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2569190     DOI： 10.1111/j.1600-0773.1989.tb00620.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN： 0901-9928


× No keyword cloud information.
  6 in total

1.  Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.

Authors:  S Uhlén; J E Wikberg
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

2.  Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem.

Authors:  G Bricca; J Zhang; H Greney; M Dontenwill; J Stutzmann; A Belcourt; P Bousquet
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

3.  Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.

Authors:  N J Mallard; A L Hudson; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

4.  A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.

Authors:  C Vayssettes-Courchay; F Bouysset; A A Cordi; M Laubie; T J Verbeuren
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

5.  Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function.

Authors:  S Diamant; T Eldar-Geva; D Atlas
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

6.  Evidence for the existence of two forms of alpha 2A-adrenoceptors in the rat.

Authors:  S Uhlén; Y Xia; V Chhajlani; E J Lien; J E Wikberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.